Justices Urged To Ax Fed. Circ. Drug Patent Obviousness Test
Accord Healthcare Inc. has told the U.S. Supreme Court that a Federal Circuit decision upholding UCB Inc.'s patent on an epilepsy drug found that the patent is not obvious by using...To view the full article, register now.
Already a subscriber? Click here to view full article